Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The legal framework for European cervical cancer screening programmes

O. Májek, A. Anttila, M. Arbyn, EB. van Veen, B. Engesæter, S. Lönnberg,

. 2019 ; 29 (2) : 345-350. [pub] 20190401

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19034989

BACKGROUND: A comprehensive legal framework needs to be developed to run the health services and to regulate the information systems required to manage and to ensure the quality of cancer screening programmes. The aim of our study was to document and to compare the status of legal basis for cervical screening registration in European countries. METHODS: An electronic questionnaire including questions on governance, decision-making structures and legal framework was developed. The primary responses were collected by September 2016. RESULTS: We sent the questionnaire to representatives of 35 European countries (28 countries of the EU, with the United Kingdom included as 4 countries; 4 EFTA member countries: Iceland, Liechtenstein, Norway, and Switzerland); responses were collected from 33 countries. The legal framework makes it possible to personally invite individuals in 29 countries (88%). Systematic screening registration in an electronic registry is legally enshrined in 23 countries (70%). Individual linkage of records between screening and cancer registries is allowed in 19 of those countries. Linkage studies involving cancer and screening registries have been conducted in 15 countries. CONCLUSION: Although the majority of EU/EFTA countries have implemented population-based screening, only half of them have successfully performed record linkage studies, which are nevertheless a key recommendation for quality assurance of the entire screening process. The European legislation is open to the possibility of using health data for these purposes; however, member states themselves must recognize the public interest to create a legal basis, which would enable all the necessary functions for high-quality cancer screening programmes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19034989
003      
CZ-PrNML
005      
20191011105942.0
007      
ta
008      
191007s2019 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/eurpub/cky200 $2 doi
035    __
$a (PubMed)30265313
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Májek, Ondřej $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics, Praha 2, Czech Republic.
245    14
$a The legal framework for European cervical cancer screening programmes / $c O. Májek, A. Anttila, M. Arbyn, EB. van Veen, B. Engesæter, S. Lönnberg,
520    9_
$a BACKGROUND: A comprehensive legal framework needs to be developed to run the health services and to regulate the information systems required to manage and to ensure the quality of cancer screening programmes. The aim of our study was to document and to compare the status of legal basis for cervical screening registration in European countries. METHODS: An electronic questionnaire including questions on governance, decision-making structures and legal framework was developed. The primary responses were collected by September 2016. RESULTS: We sent the questionnaire to representatives of 35 European countries (28 countries of the EU, with the United Kingdom included as 4 countries; 4 EFTA member countries: Iceland, Liechtenstein, Norway, and Switzerland); responses were collected from 33 countries. The legal framework makes it possible to personally invite individuals in 29 countries (88%). Systematic screening registration in an electronic registry is legally enshrined in 23 countries (70%). Individual linkage of records between screening and cancer registries is allowed in 19 of those countries. Linkage studies involving cancer and screening registries have been conducted in 15 countries. CONCLUSION: Although the majority of EU/EFTA countries have implemented population-based screening, only half of them have successfully performed record linkage studies, which are nevertheless a key recommendation for quality assurance of the entire screening process. The European legislation is open to the possibility of using health data for these purposes; however, member states themselves must recognize the public interest to create a legal basis, which would enable all the necessary functions for high-quality cancer screening programmes.
650    _2
$a důvěrnost informací $x zákonodárství a právo $7 D003219
650    _2
$a časná detekce nádoru $x metody $x normy $7 D055088
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a vytváření politiky $7 D011050
650    _2
$a registrace $x normy $7 D012042
650    _2
$a nádory děložního čípku $x diagnóza $7 D002583
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Anttila, Ahti $u Finnish Cancer Registry, Helsinki, Finland.
700    1_
$a Arbyn, Marc $u Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano, Brussels, Belgium.
700    1_
$a van Veen, Evert-Ben $u MedLawconsult, Den Haag, The Netherlands.
700    1_
$a Engesæter, Birgit $u The Norwegain cervical cancer screening programme, Cancer Registry of Norway, Oslo, Norway.
700    1_
$a Lönnberg, Stefan $u Finnish Cancer Registry, Helsinki, Finland.
773    0_
$w MED00012099 $t European journal of public health $x 1464-360X $g Roč. 29, č. 2 (2019), s. 345-350
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30265313 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191011110402 $b ABA008
999    __
$a ok $b bmc $g 1451649 $s 1073539
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 29 $c 2 $d 345-350 $e 20190401 $i 1464-360X $m European journal of public health $n Eur J Public Health $x MED00012099
LZP    __
$a Pubmed-20191007
Back

Find record

Citation metrics

Logged in users only

Archiving options